Dose: 300 mg
Single Dose: 300 (300)
Frequency: As recommended.
Route: Oral
Instructions:

. The Molecular Weight of Ethyl Biscoumacetate is 408.40.

Ethyl Biscoumacetate is contraindicated in conditions like Myocardial infarction,Liver diseases,Hypersensitivity,Pregnancy,Bleeding,Duodenal ulcer,Postpartum,Kidney disease,Breast feeding.

The severe or irreversible adverse effects of Ethyl Biscoumacetate, which give rise to further complications include Increased blood Clotting time, Prolonged bleeding.Ethyl Biscoumacetate produces potentially life-threatening effects which include Severe, Hoemmorage. which are responsible for the discontinuation of Ethyl Biscoumacetate therapy.The signs and symptoms that are produced after the acute overdosage of Ethyl Biscoumacetate include Increase bleeding.The symptomatic adverse reactions produced by Ethyl Biscoumacetate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Diarrhea, Fever, Allergic reactions.

Ethyl Biscoumacetate is primarily indicated in conditions like Pulmonary embolism, Thrombo-embolic complications, Venous thromboembolic disease.

No data regarding the interactions of Ethyl Biscoumacetate was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

During therapy required monitoring of blood coagulability. Removal of medications should be gardual.